Cyclerion Therapeutics, Inc.Cyclerion Therapeutics, Inc.Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪9.49 M‬USD
−9.07USD
‪−21.02 M‬USD
‪1.96 M‬
Beta (1Y)
−0.25

About Cyclerion Therapeutics, Inc.

Headquarters
Cambridge
Employees (FY)
1
Founded
2018
ISIN
US23255M2044
FIGI
BBG00KXXHYD9
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CYCN is 3.50 USD — it has increased by 8.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cyclerion Therapeutics, Inc. stocks are traded under the ticker CYCN.
Cyclerion Therapeutics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
CYCN stock is 11.11% volatile and has beta coefficient of −0.25. Check out the list of the most volatile stocks — is Cyclerion Therapeutics, Inc. there?
CYCN earnings for the last quarter are −6.00 USD per share, whereas the estimation was −7.20 USD resulting in a 16.67% surprise. The estimated earnings for the next quarter are −6.00 USD per share. See more details about Cyclerion Therapeutics, Inc. earnings.
Cyclerion Therapeutics, Inc. revenue for the last quarter amounts to ‪711.00 K‬ USD despite the estimated figure of ‪550.00 K‬ USD. In the next quarter revenue is expected to reach ‪355.50 K‬ USD.
Yes, you can track Cyclerion Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CYCN stock has risen by 16.67% compared to the previous week, the month change is a 19.86% rise, over the last year Cyclerion Therapeutics, Inc. has showed a 48.53% decrease.
CYCN net income for the last quarter is ‪−1.69 M‬ USD, while the quarter before that showed ‪−8.19 M‬ USD of net income which accounts for 79.31% change. Track more Cyclerion Therapeutics, Inc. financial stats to get the full picture.
Today Cyclerion Therapeutics, Inc. has the market capitalization of ‪9.49 M‬, it has increased by 1.27% over the last week.
No, CYCN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYCN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cyclerion Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CYCN reached its all-time high on Apr 2, 2019 with the price of 420.00 USD, and its all-time low was 1.75 USD and was reached on Nov 28, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 22, 2024, the company has 1.00 employees. See our rating of the largest employees — is Cyclerion Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cyclerion Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cyclerion Therapeutics, Inc. stock shows the sell signal. See more of Cyclerion Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.